Literature DB >> 3788461

Study of histomorphometric changes of the mandibular condyles in neonatal and juvenile rats after administration of cyclophosphamide.

T M Wang, C Shih.   

Abstract

Forty 1-week-old Sprague-Dawley rats were divided into 4 groups of 10 animals each. Five rats of each group served as the controls, and another 5 were given weekly intraperitoneal injections of 20 mg cyclophosphamide (CTX, Endoxan, Cytoxan) per kg of body weight. The animals of each group were sacrificed either at 1, 3, 5, or 7 weeks after initial intraperitoneal injection of CTX or water. The mandibular condyles of all rats were assayed histomorphometrically for changes on cartilage and bone cells, and other elements. The results showed a decreasing tendency in the thickness of the cartilage layer, the number of prechondroblasts, the number of chondrocytes, the percentage of cartilage matrix, the percentage of hard tissue, the bone surface perimeter, the number of osteoblasts, the number of osteoclasts, and the average number of nuclei per osteoclast in the condyles at 1 or 3 weeks after initial CTX treatment. After 7 weeks of treatment with CTX there was a significant decrease in the thickness of the cartilage layer, the number of prechondroblasts, and the numbers of both osteoblasts and osteoclasts per square millimeter of bone surface in the condyles, when compared with those of the control groups. In addition, after 5 or 7 weeks of CTX treatment there was a significant decrease in the percentage of hard tissue, the number of osteoblasts and the number of osteoclasts. Furthermore, changes in the morphology and size of the bone cells were also observed in all the rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3788461     DOI: 10.1159/000146262

Source DB:  PubMed          Journal:  Acta Anat (Basel)        ISSN: 0001-5180


  11 in total

1.  Prevention of chemotherapy-induced osteoporosis by cyclophosphamide with a long-acting form of parathyroid hormone.

Authors:  T Ponnapakkam; R Katikaneni; T Nichols; G Tobin; J Sakon; O Matsushita; R C Gensure
Journal:  J Endocrinol Invest       Date:  2011-07-12       Impact factor: 4.256

Review 2.  Cancer therapies and bone health.

Authors:  Mimi I Hu; Huifang Lu; Robert F Gagel
Journal:  Curr Rheumatol Rep       Date:  2010-06       Impact factor: 4.592

3.  Effect of anti-angiogenesis induced by chemotherapeutic monotherapy, chemotherapeutic/bisphosphonate combination therapy and anti-VEGFA mAb therapy on tooth extraction socket healing in mice.

Authors:  Yuri Akita; Shinichiro Kuroshima; Kazunori Nakajima; Hiroki Hayano; Riho Kanai; Muneteru Sasaki; Takashi Sawase
Journal:  J Bone Miner Metab       Date:  2017-10-17       Impact factor: 2.626

Review 4.  Chemotherapy-induced ovarian failure: manifestations and management.

Authors:  Julian R Molina; Debra L Barton; Charles L Loprinzi
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

5.  Do long term survivors of ewing family of tumors experience low bone mineral density and increased fracture risk?

Authors:  Gerhard M Hobusch; Iris Noebauer-Huhmann; Christoph Krall; Gerold Holzer
Journal:  Clin Orthop Relat Res       Date:  2014-07-12       Impact factor: 4.176

Review 6.  Skeletal sequelae of cancer and cancer treatment.

Authors:  Charles J Stava; Camilo Jimenez; Mimi I Hu; Rena Vassilopoulou-Sellin
Journal:  J Cancer Surviv       Date:  2009-05-02       Impact factor: 4.442

Review 7.  Skeletal manifestations of treatment of breast cancer.

Authors:  Palak Choksi; Margaret Williams; Patricia M Clark; Catherine Van Poznak
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

8.  Cyclophosphamide causes osteoporosis in C57BL/6 male mice: suppressive effects of cyclophosphamide on osteoblastogenesis and osteoclastogenesis.

Authors:  Dongfeng Zhao; Chenglong Wang; Yongjian Zhao; Bing Shu; Youji Jia; Shufen Liu; Hongshen Wang; Junli Chang; Weiwei Dai; Sheng Lu; Qi Shi; Yanping Yang; Yan Zhang; Yongjun Wang
Journal:  Oncotarget       Date:  2017-09-18

9.  Ovarian Damage During chemotherapy in Autoimmune Diseases: Broad Health Implications beyond Fertility.

Authors:  Wendy Marder; Senait Fisseha; Martha A Ganser; Emily C Somers
Journal:  Clin Med Insights Reprod Health       Date:  2012-10-24

10.  Impact of denosumab on bone mass in cancer patients.

Authors:  Ursa Brown-Glaberman; Alison T Stopeck
Journal:  Clin Pharmacol       Date:  2013-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.